1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Hunter Syndrome Treatment Market, by Type
6.1. Introduction
6.2. Enzyme Replacement Therapy
6.3. Hematopoietic Stem Cell Transplant

7. Hunter Syndrome Treatment Market, by End User
7.1. Introduction
7.2. Clinics
7.3. Home Healthcare
7.4. Hospitals

8. California Hunter Syndrome Treatment Market

9. Florida Hunter Syndrome Treatment Market

10. Illinois Hunter Syndrome Treatment Market

11. New York Hunter Syndrome Treatment Market

12. Ohio Hunter Syndrome Treatment Market

13. Pennsylvania Hunter Syndrome Treatment Market

14. Texas Hunter Syndrome Treatment Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. ArmaGen Inc.
16.2. Avrobio, Inc.
16.3. Bioasis Technologies Inc.
16.4. BioMarin Pharmaceutical Inc.
16.5. CANbridge Life Sciences Ltd.
16.6. Clinigen Group PLC
16.7. Denali Therapeutics Inc.
16.8. Esteve
16.9. GC Pharma
16.10. Inventiva S.A.
16.11. JCR Pharmaceuticals Co Ltd.
16.12. Mayo Clinic
16.13. MedlinePlus
16.14. RegenxBio Inc.
16.15. Sangamo Therapeutics, Inc.
16.16. Takeda Pharmaceutical Company Limited

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES HUNTER SYNDROME TREATMENT MARKET DYNAMICS
FIGURE 8. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANT, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 18. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOME HEALTHCARE, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. CALIFORNIA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. FLORIDA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. ILLINOIS HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. NEW YORK HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. OHIO HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. PENNSYLVANIA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. TEXAS HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 32. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 33. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES HUNTER SYNDROME TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANT, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. CALIFORNIA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 13. CALIFORNIA HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 14. CALIFORNIA HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 15. FLORIDA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 16. FLORIDA HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 17. FLORIDA HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 18. ILLINOIS HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 19. ILLINOIS HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 20. ILLINOIS HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 21. NEW YORK HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 22. NEW YORK HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 23. NEW YORK HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 24. OHIO HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 25. OHIO HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 26. OHIO HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. PENNSYLVANIA HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. PENNSYLVANIA HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 29. PENNSYLVANIA HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 30. TEXAS HUNTER SYNDROME TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. TEXAS HUNTER SYNDROME TREATMENT MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 32. TEXAS HUNTER SYNDROME TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 34. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 35. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 36. UNITED STATES HUNTER SYNDROME TREATMENT MARKET RANKING
TABLE 37. UNITED STATES HUNTER SYNDROME TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 38. UNITED STATES HUNTER SYNDROME TREATMENT MARKET MERGER & ACQUISITION
TABLE 39. UNITED STATES HUNTER SYNDROME TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 40. UNITED STATES HUNTER SYNDROME TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 41. UNITED STATES HUNTER SYNDROME TREATMENT MARKET INVESTMENT & FUNDING
TABLE 42. UNITED STATES HUNTER SYNDROME TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 43. UNITED STATES HUNTER SYNDROME TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

ArmaGen Inc.
Avrobio, Inc.
Bioasis Technologies Inc.
BioMarin Pharmaceutical Inc.
CANbridge Life Sciences Ltd.
Clinigen Group PLC
Denali Therapeutics Inc.
Esteve
GC Pharma
Inventiva S.A.
JCR Pharmaceuticals Co Ltd.
Mayo Clinic
MedlinePlus
RegenxBio Inc.
Sangamo Therapeutics, Inc.
Takeda Pharmaceutical Company Limited